Showing results (81-90 of 366) with videos related to
Sort By:
Pageof 37
Clinical and Experimental Rheumatology|September 1, 1989
Rheumatoid arthritis and chronic lymphatic leukaemiaH G Taylor, N Nixon, T P Sheeran, et al.Genes and Immunity|July 15, 2011
Influence of variations across the MMP-1 and -3 genes on the serum levels of MMP-1 and -3 and disease activity in rheumatoid arthritisY Chen, N B Nixon, P T Dawes, et al.The Journal of Rheumatology|October 1, 1983
Acetylator phenotype and the effect of dapsone in rheumatoid arthritisP R Crook, C Hortas, E J Roberts, et al.Postgraduate Medical Journal|January 1, 1994
Persistent monoarthritis and occult coeliac diseaseA A Borg, P T Dawes, C H Swan, et al.Clinical Rheumatology|June 28, 2000
How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional studyF N Birrell, A B Hassell, P W Jones, et al.The Journal of Rheumatology|March 25, 1999
Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathyA M Salih, N B Nixon, P T Dawes, et al.Clinical and Experimental Rheumatology|December 9, 1998
Prevalence of antibodies to neurofilament polypeptides in patients with rheumatoid arthritis complicated by peripheral neuropathyA M Salih, N B Nixon, P T Dawes, et al.Clinical and Experimental Rheumatology|March 23, 2000
Antibodies to neuroblastoma cells in rheumatoid arthritis: a potential marker for neuropathyA M Salih, N B Nixon, P T Dawes, et al.The Journal of Rheumatology|September 11, 1998
Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RAF N Birrell, A B Hassell, P W Jones, et al.Journal of the Royal College of Physicians of London|April 1, 1992
Medical audit: the differing perspectives of managers and cliniciansH E Smith, G I Russell, A J Frew, et al.Pageof 37